TY - JOUR
T1 - Increase of nitrosative stress in patients with eosinophilic pneumonia
AU - Furukawa, Kanako
AU - Sugiura, Hisatoshi
AU - Matsunaga, Kazuto
AU - Ichikawa, Tomohiro
AU - Koarai, Akira
AU - Hirano, Tsunahiko
AU - Yanagisawa, Satoru
AU - Minakata, Yoshiaki
AU - Akamatsu, Keiichiro
AU - Kanda, Masae
AU - Nishigai, Manabu
AU - Ichinose, Masakazu
PY - 2011/6/17
Y1 - 2011/6/17
N2 - Background: Exhaled nitric oxide (NO) production is increased in asthma and reflects the degree of airway inflammation. The alveolar NO concentration (Calv) in interstitial pneumonia is reported to be increased. However, it remains unknown whether NO production is increased and nitrosative stress occurs in eosinophilic pneumonia (EP). We hypothesized that nitrosative stress markers including Calv, inducible type of NO synthase (iNOS), and 3-nitrotyrosine (3-NT), are upregulated in EP.Methods: Exhaled NO including fractional exhaled NO (FENO) and Calv was measured in ten healthy subjects, 13 patients with idiopathic pulmonary fibrosis (IPF), and 13 patients with EP. iNOS expression and 3-NT formation were assessed by immunocytochemistory in BALf cells. The exhaled NO, lung function, and systemic inflammatory markers of the EP patients were investigated after corticosteroid treatment for 4 weeks.Results: The Calv levels in the EP group (14.4 ± 2.0 ppb) were significantly higher than those in the healthy subjects (5.1 ± 0.6 ppb, p < 0.01) and the IPF groups (6.3 ± 0.6 ppb, p < 0.01) as well as the FENO and the corrected Calv levels (all p < 0.01). More iNOS and 3-NT positive cells were observed in the EP group compared to the healthy subject and IPF patient. The Calv levels had significant positive correlations with both iNOS (r = 0.858, p < 0.05) and 3-NT positive cells (r = 0.924, p < 0.01). Corticosteroid treatment significantly reduced both the FENO (p < 0.05) and the Calv levels (p < 0.01). The magnitude of reduction in the Calv levels had a significant positive correlation with the peripheral blood eosinophil counts (r = 0.802, p < 0.05).Conclusions: These results suggested that excessive nitrosative stress occurred in EP and that Calv could be a marker of the disease activity.
AB - Background: Exhaled nitric oxide (NO) production is increased in asthma and reflects the degree of airway inflammation. The alveolar NO concentration (Calv) in interstitial pneumonia is reported to be increased. However, it remains unknown whether NO production is increased and nitrosative stress occurs in eosinophilic pneumonia (EP). We hypothesized that nitrosative stress markers including Calv, inducible type of NO synthase (iNOS), and 3-nitrotyrosine (3-NT), are upregulated in EP.Methods: Exhaled NO including fractional exhaled NO (FENO) and Calv was measured in ten healthy subjects, 13 patients with idiopathic pulmonary fibrosis (IPF), and 13 patients with EP. iNOS expression and 3-NT formation were assessed by immunocytochemistory in BALf cells. The exhaled NO, lung function, and systemic inflammatory markers of the EP patients were investigated after corticosteroid treatment for 4 weeks.Results: The Calv levels in the EP group (14.4 ± 2.0 ppb) were significantly higher than those in the healthy subjects (5.1 ± 0.6 ppb, p < 0.01) and the IPF groups (6.3 ± 0.6 ppb, p < 0.01) as well as the FENO and the corrected Calv levels (all p < 0.01). More iNOS and 3-NT positive cells were observed in the EP group compared to the healthy subject and IPF patient. The Calv levels had significant positive correlations with both iNOS (r = 0.858, p < 0.05) and 3-NT positive cells (r = 0.924, p < 0.01). Corticosteroid treatment significantly reduced both the FENO (p < 0.05) and the Calv levels (p < 0.01). The magnitude of reduction in the Calv levels had a significant positive correlation with the peripheral blood eosinophil counts (r = 0.802, p < 0.05).Conclusions: These results suggested that excessive nitrosative stress occurred in EP and that Calv could be a marker of the disease activity.
KW - 3-nitrotyrosine
KW - Alveolar nitric oxide
KW - Corticosteroid
KW - Fractional exhaled nitric oxide
KW - Inducible type of nitric oxide synthase
UR - http://www.scopus.com/inward/record.url?scp=79958794028&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79958794028&partnerID=8YFLogxK
U2 - 10.1186/1465-9921-12-81
DO - 10.1186/1465-9921-12-81
M3 - Article
C2 - 21679473
AN - SCOPUS:79958794028
SN - 1465-9921
VL - 12
JO - Respiratory Research
JF - Respiratory Research
M1 - 81
ER -